The chemical class known as TRIM56 Activators encompasses a group of compounds that have the potential to modulate the activity of the TRIM56 protein. TRIM56, a member of the tripartite motif (TRIM) family of proteins, plays a crucial role in various cellular processes, including innate immunity and antiviral defense mechanisms.
One such indirect activator of TRIM56 is Poly(I:C), a synthetic analog of double-stranded RNA (dsRNA). Poly(I:C) can stimulate the innate immune response by mimicking viral infection, leading to the activation of TRIM56 as part of the host defense against viral pathogens. This activation occurs through the recognition of dsRNA by pattern recognition receptors (PRRs), ultimately leading to the induction of interferon (IFN) signaling pathways, where TRIM56 plays a pivotal role in mediating antiviral responses. Another compound, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), has been shown to enhance the antiviral activity of TRIM56 by promoting the activation of downstream signaling pathways involved in antiviral defense. Lipopolysaccharide (LPS), a component of the outer membrane of Gram-negative bacteria, can activate TRIM56 indirectly by triggering toll-like receptor 4 (TLR4) signaling, leading to the production of proinflammatory cytokines and type I IFNs, in which TRIM56 plays a regulatory role.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $650.00 | 2 | |
Poly(I:C) is a synthetic analog of double-stranded RNA (dsRNA) commonly used to mimic viral infections. It can activate intracellular sensors like RIG-I, leading to the upregulation of TRIM56 as part of the antiviral response. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $96.00 $166.00 $459.00 $1615.00 | 12 | |
Lipopolysaccharide (LPS) is a component of the outer membrane of Gram-negative bacteria. It activates Toll-like receptor 4 (TLR4), triggering signaling cascades that indirectly affect TRIM56 expression as part of the immune response. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $100.00 $300.00 $500.00 $1528.00 | 12 | |
Resiquimod is a TLR7 and TLR8 agonist. Activation of TLR7 or TLR8 initiates immune responses that indirectly influence TRIM56 expression. | ||||||